Skip to main content
Journal of Dental Sciences logoLink to Journal of Dental Sciences
letter
. 2022 Jun 29;17(4):1833–1834. doi: 10.1016/j.jds.2022.06.009

Two-hit theory by estrogen in burning mouth syndrome

Takahiko Nagamine 1,2,
PMCID: PMC9588802  PMID: 36299303

Burning mouth syndrome (BMS) is characterized by chronic burning pain in a normal-appearing oral mucosa. An important implication regarding the mechanism of pathogenesis is that the disease generally develops in postmenopausal women. I read with great interest the paper by Seol et al. on the regulation of transient receptor potential vanilloid 1 (TRPV1) as an estrogen-dependent nociceptor in BMS patients.1 They argued that estrogen has both pro-nociceptive and anti-nociceptive effects via modulation of nociceptors. Estrogen upregulates TRPV1 through classical genomic and non-classical pathways, resulting in pro-nociceptive effect. On the other hand, estrogen alleviates pain by downregulating nerve growth factor (NGF), which can translocate TRPV1 to the cell surface membrane.

How do the opposing effects of estrogen on pain perception affect the development of BMS? As a first hit by estrogen, increased estrogen during puberty increases TRPV1 expression, making at-risk individuals more sensitive to pain and more pain induced by dental treatment. In fact, BMS patients may have migraine headaches related to TRIPV1 and neuroinflammation prior to the onset of BMS.2 As a second hit by estrogen, when estrogen decreases during menopause, NGF increases, TRPV1 increases at the cell surface, pain sensitivity increases, neuroinflammation also occurs, and BMS develops in at-risk individuals. In fact, TRPV1 expression is increased in the oral mucosa of BMS patients.3 Two-hit by estrogen may explain gender differences in BMS patients. However, future studies on changes in estrogen and TRPV1 expression and rigorous investigation of pre-existing painful conditions in BMS patients are needed to validate this.

Declaration of competing interest

The author has no conflicts of interest relevant to this article.

Acknowledgments

This study has no source of fundings.

References

  • 1.Seol S.H., Chung G. Estrogen-dependent regulation of transient receptor potential vanilloid 1 (TRPV1) and P2X purinoceptor 3 (P2X3): implication in burning mouth syndrome. J Dent Sci. 2022;17:8–13. doi: 10.1016/j.jds.2021.06.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Kim D.K., Lee H.J., Lee I.H., et al. Risk of burning mouth syndrome in patients with migraine: a nationwide cohort study. J Pers Med. 2022;12:620. doi: 10.3390/jpm12040620. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Yilmaz Z., Renton T., Yiangou Y., et al. Burning mouth syndrome as a trigeminal small fibre neuropathy: increased heat and capsaicin receptor TRPV1 in nerve fibres correlates with pain score. J Clin Neurosci. 2007;14:864–871. doi: 10.1016/j.jocn.2006.09.002. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Dental Sciences are provided here courtesy of Association for Dental Sciences of the Republic of China

RESOURCES